In support of this, one study showed that the majority (77/116, 78%) of B-cell lymphoproliferative disease expressed BAFF-R [51] while others [52] demonstrate that as well as BAFF-R B-cell lymphomas could also express the other BAFF receptors (BCMA and TACI). This evidence concerns the gene TNFRSF13B and B-cell non-Hodgkin lymphoma.